natgillin/translations-raw huggingface dataset:
CDP-choline in oral solution as source of choline contributes to the maintenance of normal function of the ophthalmic nervous structures
CDP-kolin u oralnoj otopini kao izvor kolina pridonosi održavanju normalne funkcije živčanih struktura oka
Helps/supports/maintains concentration
Poboljšava/podupire/održava koncentraciju
Commission Regulation (EU) 2015/403
Uredba Komisije (EU) 2015/403
amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards Ephedra species and Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille)
o izmjeni Priloga III. Uredbi (EZ) br. 1925/2006 Europskog parlamenta i Vijeća u pogledu vrsta Ephedra i Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille)
Having regard to Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of vitamins and minerals and of certain other substances to foods [1], and in particular Article 8(2) thereof,
uzimajući u obzir Uredbu (EZ) br. 1925/2006 Europskog parlamenta i Vijeća od 20. prosinca 2006. o dodavanju vitamina, minerala i određenih drugih tvari hrani [1], a posebno njezin članak 8. stavak 2.,
Pursuant to Article 8(2) of Regulation (EC) No 1925/2006, a Member State may request the Commission to initiate a procedure to include a substance or an ingredient containing a substance other than a vitamin or a mineral in Annex III to Regulation (EC) No 1925/2006 listing the substances whose use in foods is prohibited, restricted or under Union scrutiny, if that substance is associated with a potential risk to consumers as defined by Article 8(1) of Regulation (EC) No 1925/2006.
U skladu s člankom 8. stavkom 2. Uredbe (EZ) br. 1925/2006 država članica može od Komisije zatražiti da pokrene postupak za uključivanje tvari ili sastojka koji sadržava tvar koja nije vitamin ili mineral u Prilog III. Uredbi (EZ) br. 1925/2006 u kojem su navedene tvari čija je uporaba u hrani zabranjena, ograničena ili pod nadzorom Unije, ako bi ta tvar mogla predstavljati opasnost za potrošače kao što je definirano u članku 8. stavku 1. Uredbe (EZ) br. 1925/2006.
On 7 September 2009, Germany sent a request to the Commission regarding the possible harmful effects associated with the intake of Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) and Ephedra species and their preparations, and asked the Commission to initiate the procedure under Article 8 of Regulation (EC) No 1925/2006 for those two substances.
Njemačka je 7. rujna 2009. poslala Komisiji zahtjev u vezi s mogućim štetnim učincima povezanim s unosom vrsta Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) i Ephedra i njihovih pripravaka te je zatražila od Komisije da pokrene postupak u skladu s člankom 8. Uredbe (EZ) br. 1925/2006 za te dvije tvari.
The request by Germany fulfilled the necessary conditions and requirements laid down in Articles 3 and 4 of Commission Implementing Regulation (EU) No 307/2012 [2].
Zahtjev Njemačke ispunjavao je potrebne uvjete i zahtjeve propisane člancima 3. i 4. Provedbene uredbe Komisije (EU) br. 307/2012 [2].
On 9 September 2011, the Commission asked the European Food Safety Authority (hereafter ‘the Authority’) to evaluate the safety in use of Ephedra and Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) species in food.
Komisija je 9. rujna 2011. zatražila od Europske agencije za sigurnost hrane (dalje u tekstu: „Agencija”) da procijeni sigurnost uporabe vrsta Ephedra i Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) u hrani.
On 3 July 2013, the Authority adopted a scientific opinion on the evaluation of the safety in use of Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) [3].
Agencija je 3. srpnja 2013. donijela znanstveno mišljenje o procjeni sigurnosti uporabe vrste Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) [3].
It concluded that the chemical and toxicological characterisation of yohimbe bark and its preparations used in food originating from Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) are not adequate to conclude on their safety as ingredients of food.
Zaključila je da kemijska i toksikološka svojstva kore yohimbe i njezinih pripravaka koji se koriste u hrani s podrijetlom od Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) nisu primjereni za donošenje zaključka o njihovoj sigurnosti kao sastojaka u hrani.
Therefore, it was not possible for the Authority to provide advice on a daily intake of yohimbe bark and its preparations that does not give rise to concerns for human health.
Stoga Agencija nije mogla dati savjet o dnevnom unosu kore yohimbe i njezinih pripravaka koji ne bi izazivao zabrinutost za zdravlje ljudi.
On 6 November 2013, the Authority adopted a scientific opinion on the safety evaluation of Ephedra species for use in food [4].
Agencija je 6. studenoga 2013. donijela znanstveno mišljenje o sigurnosti procjene uporabe vrste Ephedra u hrani [4].
It found that although the marketing of foods containing Ephedra herb and its preparations in retail outlets is not documented in Europe, food supplements containing Ephedra herbs or their preparations that are typically used for weight loss and athletic performance can easily be purchased via the internet.
Otkrila je da se, iako stavljanje na tržište hrane koja sadržava biljku Ephedra i njezine pripravke na maloprodajnim mjestima nije dokumentirano u Europi, dodaci prehrani koji sadržavaju biljke Ephedra ili njihove pripravke koji se obično upotrebljavaju za gubitak tjelesne mase i postizanje atletskih rezultata lako mogu kupiti putem interneta.
The Authority concluded that it cannot be excluded that consumers may purchase herbal tea from Ephedra herb via the internet.
Agencija je zaključila da se ne može isključiti mogućnost da potrošači putem interneta kupe biljni čaj od biljke Ephedra.
Given that Ephedra herb and its preparations are marketed almost exclusively as food supplements, the Authority calculated potential exposure levels to the herb from food supplements.
S obzirom na to da se biljka Ephedra i njezini pripravci stavljaju na tržište gotovo isključivo kao dodaci prehrani, Agencija je izračunala potencijalne razine izloženosti biljci iz dodataka prehrani.
It concluded that Ephedra herb and its preparations in food supplements may result in exposure to total ephedra alkaloids or ephedrine which falls within or may exceed the therapeutic dose ranges for the individual ephedra alkaloids or ephedrine, in medicinal products.
Zaključila je da biljka Ephedra i njezini pripravci u dodacima prehrani mogu rezultirati izlaganjem ukupnim alkaloidima ephedre ili ephedrina koji su obuhvaćeni terapeutskim rasponom doze za pojedine alkaloide ephedre ili ephedrina u lijekovima ili koji ga mogu premašiti.
The Authority concluded that due to the absence of adequate toxicity data, it could not provide advice on a daily intake of Ephedra herb and its preparations from all foods that does not give rise to concerns for human health.
Agencija je zaključila da zbog nedostatka odgovarajućih podataka o toksičnosti ne može dati savjet o dnevnom unosu biljke Ephedra i njezinim pripravcima iz sve hrane koji ne bi izazivao zabrinutost za zdravlje ljudi.
Nevertheless, it concluded that exposure to total ephedra alkaloids or ephedrine in foods, mainly in food supplements could lead to severe adverse effects on the cardiovascular and central nervous systems (such as hypertension and stroke), which may be enhanced in combination with caffeine.
Unatoč tome, zaključila je da izlaganje ukupnim alkaloidima ephedre ili ephedrinu u hrani, uglavnom u dodacima prehrani, može uzrokovati teške negativne učinke za kardiovaskularni i središnji živčani sustav (kao što su povišeni krvni tlak i moždani udar), koji mogu biti još pojačani u kombinaciji s kofeinom.
Therefore, the use of Ephedra herb and its preparations containing ephedra alkaloids in food is of significant safety concern for human health.
Stoga uporaba biljke Ephedra i njezinih pripravaka koji sadržavaju alkaloide ephedre u hrani izaziva znatnu zabrinutost za zdravlje ljudi.
The Commission received no comments from interested parties following publication by the Authority of its opinions on Ephedra species and on Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille).
Komisija od zainteresiranih strana nije primila nikakve primjedbe nakon što je Agencija objavila svoje mišljenje o vrstama Ephedra i Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille).
As there is a possibility of harmful effects on health associated with the use of Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) and its preparations in foods, but scientific uncertainty persists, the substance should be placed under Union scrutiny and therefore, should be included in Part C of Annex III to Regulation (EC) No 1925/2006.
S obzirom na to da postoji mogućnost negativnih učinaka na zdravlje povezanih s uporabom vrste Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) i njezinih pripravaka u hrani, ali postoji znanstvena nesigurnost, tvar je potrebno staviti pod nadzor Unije i stoga ona treba biti uključena u dio C Priloga III. Uredbi (EZ) br. 1925/2006.
Consequently, during the period of Union scrutiny and pending a decision on whether to allow the use of the substance or to place it in Part A or B of Annex III to Regulation (EC) No 1925/2006 at the end of the scrutiny period, national provisions regulating the use of Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) in food should still apply.
Stoga se tijekom razdoblja nadzora Unije i dok se čeka na odluku treba li dopustiti uporabu tvari ili je na kraju razdoblja nadzora staviti u dio A ili dio B Priloga III. Uredbi (EZ) br. 1925/2006 i dalje trebaju primjenjivati nacionalne odredbe kojima se regulira uporaba vrste Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille) u hrani.
Considering the significant safety concern associated with the use of Ephedra herb and its preparations in foods, in particular with regard to exposure to ephedra alkaloids present in food supplements, and considering that no daily intake of Ephedra herb and its preparations that does not give rise to concerns for human health could be set, the use of that substance in foods should be prohibited.
S obzirom na znatnu zabrinutost za sigurnost u vezi s uporabom biljke Ephedra i njezinih pripravaka u hrani, a pogotovo u vezi s izlaganjem alkaloidima ephedre prisutnima u dodacima prehrani i s obzirom na to da se ne može odrediti dnevni unos biljke Ephedra i njezinih pripravaka koji ne bi izazivao zabrinutost za zdravlje ljudi, potrebno je zabraniti uporabu te tvari u hrani.
Therefore, Ephedra herb and its preparations should be included in Annex III, Part A of Regulation (EC) No 1925/2006.
Stoga biljku Ephedra i njezine pripravke treba uključiti u Prilog III. dio A Uredbe (EZ) br. 1925/2006.
Annex III to Regulation (EC) No 1925/2006 is amended as follows:
Prilog III. Uredbi (EZ) br. 1925/2006 mijenja se kako slijedi:
in Part A, the following entry is added:
U dijelu A dodaje se sljedeća točka:
‘Ephedra herb and its preparations originating from Ephedra species’
„Biljka Ephedra i njezini pripravci podrijetlom od vrste Ephedra”
in Part C, the following entry is added:
U dijelu C dodaje se sljedeća točka:
‘Yohimbe bark and its preparations originating from Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille)’
„Kora Yohimbe i njezini pripravci podrijetlom od vrste Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille)”
OJ L 404, 30.12.2006, p. 26.
SL L 404, 30.12.2006., str. 26.
Commission Implementing Regulation (EU) No 307/2012 of 11 April 2012 establishing implementing rules for the application of Article 8 of Regulation (EC) No 1925/2006 of the European Parliament and of the Council on the addition of vitamins and minerals and of certain other substances to foods (OJ L 102, 12.4.2012, p. 2).
Provedbena uredba Komisije (EU) br. 307/2012 od 11. travnja 2012. o utvrđivanju provedbenih pravila za primjenu članka 8. Uredbe (EZ) br. 1925/2006 Europskog parlamenta i Vijeća o dodavanju vitamina, minerala i određenih drugih tvari hrani (SL L 102, 12.4.2012., str. 2.).
EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS); Scientific Opinion on safety evaluation of Ephedra species for use in food.
Znanstveni odbor EFSA-e za prehrambene aditive i hranjive tvari dodane hrani (ANS); Znanstveno mišljenje o procjeni sigurnosti uporabe vrste Ephedra u hrani.
EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS); Scientific Opinion on the evaluation of the safety in use of Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille).
Znanstveni odbor EFSA-e za prehrambene aditive i hranjive tvari dodane hrani (ANS); Znanstveno mišljenje o procjeni sigurnosti uporabe vrste Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille).
EFSA Journal 2013;11(7):3302.
EFSA Journal 2013.; 11(7):3302.
EFSA Journal 2013;11(11):3467.
EFSA Journal 2013.; 11(11):3467.
Commission Implementing Regulation (EU) 2015/404
Provedbena uredba Komisije (EU) 2015/404
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances beflubutamid, captan, dimethoate, dimethomorph, ethoprophos, fipronil, folpet, formetanate, glufosinate, methiocarb, metribuzin, phosmet, pirimiphos-methyl and propamocarb
o izmjeni Provedbene uredbe (EU) br. 540/2011 u pogledu produljenja rokova valjanosti odobrenja aktivnih tvari beflubutamida, kaptana, dimetoata, dimetomorfa, etoprofosa, fipronila, folpeta, formetanata, glufosinata, metiokarba, metribuzina, fosmeta, pirimifos-metila i propamokarba
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC [1], and in particular the first paragraph of Article 17 thereof,
uzimajući u obzir Uredbu (EZ) br. 1107/2009 Europskog parlamenta i Vijeća od 21. listopada 2009. o stavljanju na tržište sredstava za zaštitu bilja i stavljanju izvan snage direktiva Vijeća 79/117/EEZ i 91/414/EEZ [1], a posebno njezin članak 17. prvi stavak,
Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 [2] sets out the active substances deemed to have been approved under Regulation (EC) No 1107/2009.
U dijelu A Priloga Provedbenoj uredbi Komisije (EU) br. 540/2011 [2] utvrđene su aktivne tvari koje se smatraju odobrenima na temelju Uredbe (EZ) br. 1107/2009.
As the requirements laid down in Commission Implementing Regulation (EU) No 844/2012 [3] apply to those active substances, it is necessary to provide for sufficient time to complete the renewal procedure in accordance with that Regulation.
S obzirom na to da se na navedene aktivne tvari primjenjuju zahtjevi iz Provedbene uredbe Komisije (EU) br. 844/2012 [3], treba ostaviti dovoljno vremena za postupak obnove u skladu s tom Uredbom.
Consequently, the approvals of those active substances are likely to expire before a decision has been taken on their renewal.
Zato je vjerojatno da će valjanost odobrenja tih aktivnih tvari isteći prije donošenja odluke o njihovoj obnovi.
It is therefore necessary to extend their approval periods.
Stoga je potrebno produljiti rok valjanosti tih odobrenja.
Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.
Provedbenu uredbu (EU) br. 540/2011 treba stoga na odgovarajući način izmijeniti.
In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where no supplementary dossier in accordance with Implementing Regulation (EU) No 844/2012 is submitted no later than 30 months before the respective expiry date laid down in the Annex to this Regulation, the Commission will set the expiry date at the same date as before this Regulation or at the earliest date thereafter.
S obzirom na cilj članka 17. prvog stavka Uredbe (EZ) br. 1107/2009, u slučajevima kada dodatna dokumentacija u skladu s Provedbenom uredbom (EU) br. 844/2012 nije dostavljena najkasnije 30 mjeseci prije datuma prestanka valjanosti utvrđenog u Prilogu toj Uredbi, Komisija će kao datum prestanka valjanosti odrediti isti datum koji je vrijedio prije donošenja ove Uredbe ili najraniji mogući datum nakon tog datuma.
In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where the Commission will adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission will set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later.
S obzirom na cilj članka 17. prvog stavka Uredbe (EZ) br. 1107/2009, u slučajevima kada Komisija donese uredbu kojom se predviđa da se odobrenje aktivne tvari iz Priloga ovoj Uredbi ne obnavlja jer nisu ispunjeni uvjeti za izdavanje odobrenja, Komisija će kao datum prestanka valjanosti odrediti isti datum koji je vrijedio prije donošenja ove Uredbe ili datum stupanja na snagu uredbe kojom se predviđa da se odobrenje aktivne tvari ne obnavlja, ovisno o tome koji je datum kasniji.
Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26).
Provedbena uredba Komisije (EU) br. 844/2012 od 18. rujna 2012. o određivanju odredaba potrebnih za provedbu postupka obnavljanja odobrenja za aktivne tvari, kako je predviđeno Uredbom (EZ) br. 1107/2009 Europskog parlamenta i Vijeća o stavljanju na tržište sredstava za zaštitu bilja (SL L 252, 19.9.2012., str. 26.).
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
Dio A Priloga Provedbenoj uredbi (EU) br. 540/2011 mijenja se kako slijedi:
in the sixth column, expiration of approval, of row 145, captan, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
U šestom stupcu, prestanak odobrenja, u retku 145., kaptan, datum „30. rujna 2017.” zamjenjuje se datumom „31. srpnja 2018.”
in the sixth column, expiration of approval, of row 146, folpet, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
U šestom stupcu, prestanak odobrenja, u retku 146., folpet, datum „30. rujna 2017.” zamjenjuje se datumom „31. srpnja 2018.”
in the sixth column, expiration of approval, of row 147, formetanate, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
U šestom stupcu, prestanak odobrenja, u retku 147., formetanat, datum „30. rujna 2017.” zamjenjuje se datumom „31. srpnja 2018.”
in the sixth column, expiration of approval, of row 148, methiocarb, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
U šestom stupcu, prestanak odobrenja, u retku 148., metiokarb, datum „30. rujna 2017.” zamjenjuje se datumom „31. srpnja 2018.”
in the sixth column, expiration of approval, of row 149, dimethoate, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
U šestom stupcu, prestanak odobrenja, u retku 149., dimetoat, datum „30. rujna 2017.” zamjenjuje se datumom „31. srpnja 2018.”
in the sixth column, expiration of approval, of row 150, dimethomorph, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
U šestom stupcu, prestanak odobrenja, u retku 150., dimetomorf, datum „30. rujna 2017.” zamjenjuje se datumom „31. srpnja 2018.”
in the sixth column, expiration of approval, of row 151, glufosinate, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
U šestom stupcu, prestanak odobrenja, u retku 151., glufosinat, datum „30. rujna 2017.” zamjenjuje se datumom „31. srpnja 2018.”
in the sixth column, expiration of approval, of row 152, metribuzin, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
U šestom stupcu, prestanak odobrenja, u retku 152., metribuzin, datum „30. rujna 2017.” zamjenjuje se datumom „31. srpnja 2018.”
in the sixth column, expiration of approval, of row 153, phosmet, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
U šestom stupcu, prestanak odobrenja, u retku 153., fosmet, datum „30. rujna 2017.” zamjenjuje se datumom „31. srpnja 2018.”
in the sixth column, expiration of approval, of row 154, propamocarb, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
U šestom stupcu, prestanak odobrenja, u retku 154., propamokarb, datum „30. rujna 2017.” zamjenjuje se datumom „31. srpnja 2018.”
in the sixth column, expiration of approval, of row 155, ethoprophos, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
U šestom stupcu, prestanak odobrenja, u retku 155., etoprofos, datum „30. rujna 2017.” zamjenjuje se datumom „31. srpnja 2018.”
in the sixth column, expiration of approval, of row 156, pirimiphos-methyl, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
U šestom stupcu, prestanak odobrenja, u retku 156., pirimifos-metil, datum „30. rujna 2017.” zamjenjuje se datumom „31. srpnja 2018.”
in the sixth column, expiration of approval, of row 157, fipronil, the date of ‘30 September 2017’ is replaced by ‘31 July 2018’;
U šestom stupcu, prestanak odobrenja, u retku 157., fipronil, datum „30. rujna 2017.” zamjenjuje se datumom „31. srpnja 2018.”
in the sixth column, expiration of approval, of row 158, beflubutamid, the date of ‘30 November 2017’ is replaced by ‘31 July 2018’.
U šestom stupcu, prestanak odobrenja, u retku 158., beflubutamid, datum „30. studenoga 2017.” zamjenjuje se datumom „31. srpnja 2018.”
The approvals of the active substances captan, dimethoate, dimethomorph, ethoprophos, fipronil, folpet, formetanate, glufosinate, methiocarb, metribuzin, phosmet, pirimiphos-methyl and propamocarb will expire on 30 September 2017 and that of the active substance beflubutamid will expire on 30 November 2017.
Odobrenja aktivnih tvari kaptana, dimetoata, dimetomorfa, etoprofosa, fipronila, folpeta, formetanata, glufosinata, metiokarba, metribuzina, fosmeta, pirimifos-metila i propamokarba ističu 30. rujna 2017., a odobrenje aktivne tvari beflubutamida ističe 30. studenoga 2017.
Applications have been submitted for the renewal of the approval of those active substances.
Podneseni su zahtjevi za obnovu odobrenja tih aktivnih tvari.
Commission Implementing Regulation (EU) 2015/405
Provedbena uredba Komisije (EU) 2015/405
approving alpha-cypermethrin as an active substance for use in biocidal products for product-type 18
o odobrenju alfa-cipermetrina kao aktivne tvari za uporabu u biocidnim proizvodima za vrstu proizvoda 18
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products [1], and in particular the third subparagraph of Article 89(1) thereof,
Uzimajući u obzir Uredbu (EU) br. 528/2012 Europskog parlamenta i Vijeća od 22. svibnja 2012. o stavljanju na raspolaganje na tržištu i uporabi biocidnih proizvoda [1], a posebno njezin članak 89. stavak 1. treći podstavak,
Commission Delegated Regulation (EU) No 1062/2014 [2] establishes a list of active substances to be evaluated with a view to their possible approval for use in biocidal products or inclusion into Annex I to Regulation (EU) No 528/2012.
Delegiranom uredbom Komisije (EU) br. 1062/2014 [2] utvrđuje se popis aktivnih tvari koje treba ocijeniti s ciljem njihova mogućeg odobrenja za uporabu u biocidnim proizvodima ili njihova uključivanja u Prilog I. Uredbi (EU) br. 528/2012.
That list includes alpha-cypermethrin.
Na tom se popisu nalazi i alfa-cipermetrin.